Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction

Opioid-induced bowel dysfunction (OIBD) comprises gastrointestinal (GI) symptoms, including dry mouth, nausea, vomiting, gastric stasis, bloating, abdominal pain, and opioid-induced constipation, which significantly impair patients’ quality of life and may lead to undertreatment of pain. Traditional...

Descripción completa

Detalles Bibliográficos
Autor principal: Leppert, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404965/
https://www.ncbi.nlm.nih.gov/pubmed/25931815
http://dx.doi.org/10.2147/DDDT.S32684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404965/
https://www.ncbi.nlm.nih.gov/pubmed/25931815
http://dx.doi.org/10.2147/DDDT.S32684

Ejemplares similares